Osteolisi pseudotumorale massiva secondaria al fallimento delle protesi totali d’anca: revisione della casistica dell’Istituto Ortopedico Rizzoli e confronto con la letteratura

Title

Code

PSEUDOTUMOR

Type

Osservazionale

Start Year

2022

Status

In Corso

Principal Investigator

051-6366455

laura.campanacci@ior.it

Campanacci Laura, MD

3rd Orthopaedic and Traumatologic Clinic prevalently Oncologic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica III a prevalente indirizzo Oncologico

Director

Donati Davide Maria, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. PSEUDOTUMOR

Monday 4 July 2022, 14:21

PG0010400_2022_PSEUDOTUMOR.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Osteolisi pseudotumorale massiva secondaria al fallimento delle protesi totali d’anca: revisione della casistica dell’Istituto Ortopedico Rizzoli e confronto con la letteratura

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Osteolisi pseudotumorale massiva secondaria al fallimento delle protesi totali d’anca: revisione della casistica dell’Istituto Ortopedico Rizzoli e confronto con la letteratura

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in